Exploring the Effects of Probiotics on Workplace Related Stress Symptoms

August 26, 2024 updated by: Chi-Chang Huang, National Taiwan Sport University
There is still a lack of research to explore the interaction between high-pressure workers and probiotics to improve the intestinal microbiota, sleep, inflammation and anti-oxidation. A total of 120 subjects are expected to be recruited and divided into two groups of 60 subjects, receiving probiotics or placebo, and completing a 8-week trial period.

Study Overview

Status

Completed

Conditions

Detailed Description

This is a double blind, randomized control study, which will be conducted by National Taiwan Sport University. A total of 120 subjects are expected to be recruited and divided into two groups of 60 subjects, receiving probiotics or placebo, and completing a 8-week trial period. Volunteers will be asked to fill in the Perceived Stress Scale questionnaire before recruiting. Subjects who meet the criteria will be asked to fill the different questionnaires to evaluate their stress, emotions, gastrointestinal tract symptoms, sleep status and blood draw is also needed.

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taoyuan, Taiwan, 33301
        • Graduate Institute of Sports Science, National Taiwan Sport University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 20 to 60 years old
  • Perceived Stress Scale (PSS) score is greater than or equal to 14 points

Exclusion Criteria:

  • Have used antibiotics or probiotic products in powder, capsule or tablet form within one month
  • Those who are taking Chinese medicine or Western medicine to treat severe acute diseases
  • Patients with uncontrolled high blood pressure or diabetes, a history of cancer, and mental illness
  • Pregnant or breastfeeding
  • Those who have participated in other interventional clinical studies in the past three months
  • Who has conflict of interest with PI or unsuitable to participate in the research such as students directly supervised by the project host and those who are unable to read the consent form

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: probiotics
Probiotic capsules
each capsule contains Lactiplantibacillus plantarum and Lacticaseibacillus paracasei, 2 caps daily use
Placebo Comparator: placebo
Placebo capsules
The placebo capsule contains microcrystalline cellulose, 2 caps daily use.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cortisol
Time Frame: From Baseline to 8 Weeks Assessed
Cortisol is a steroid hormone that is produced by the adrenal glands which sit on top of each kidney. When released into the bloodstream, cortisol can act on many different parts of the body and can help: body respond to stress or danger increase body's metabolism of glucose control blood pressure reduce inflammation. Cortisol is also needed for the fight or flight response which is a healthy, natural response to perceived threats. The amount of cortisol produced is highly regulated by body to ensure the balance is correct.
From Baseline to 8 Weeks Assessed

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived Stress Scale (PSS)
Time Frame: From Baseline to 8 Weeks Assessed
The PSS scores is a rating tool used to gauge the course of stree. The minimum total score possible is 0 and the maximum total score possible is 40. Higher values represent a worse outcome.
From Baseline to 8 Weeks Assessed
Job Stress Scale
Time Frame: From Baseline to 8 Weeks Assessed
The job stress scale from Ministry of Labor is a rating tool used to gauge of stress.
From Baseline to 8 Weeks Assessed
Overwork Survey
Time Frame: From Baseline to 8 Weeks Assessed
This survey is used as self-evaluation of whether an employee overworks, based on the Overwork Survey by Occupational Safety and Health Administration, Ministry of Labor. The survey includes personal-related overwork and work-related overwork.
From Baseline to 8 Weeks Assessed
Insomnia Severity index (ISI)
Time Frame: From Baseline to 8 Weeks Assessed
The ISI is a rating tool used to gauge of sleeping. Higher values represent a worse outcome.The minimum total score possible is 0 and the maximum total score possible is 28. Higher values represent a worse outcome.
From Baseline to 8 Weeks Assessed
The State Trait Anxiety Inventory (STAI)
Time Frame: From Baseline to 8 Weeks Assessed
The State-Trait Anxiety Inventory (STAI) is a commonly used measure of trait and state anxiety. All items are rated on a 4-point scale (e.g., from "Almost Never" to "Almost Always"). Higher scores indicate greater anxiety.
From Baseline to 8 Weeks Assessed
Depression Anxiety Stress Scales (DASS-42)
Time Frame: From Baseline to 8 Weeks Assessed
The measure of stress with stress subscale in magnesium and placebo groups will be performed in order to assess the impact of the dietary supplement on this parameter. This subscale consists of 14 questions of self-evaluation, each of them emphasizing a negative emotional symptom, these feelings of uselessness and hopelessness. Each element is evaluated from zero to three, zero being "not present" and three being "very frequently". It assesses mental health by measuring the severity of stress
From Baseline to 8 Weeks Assessed
The Quality of Life, Enjoyment, and Satisfaction Questionnaire-16, QLESQ-16
Time Frame: From Baseline to 8 Weeks Assessed
The Quality of Life, Enjoyment, and Satisfaction Questionnaire-16 (QLESQ-16) is a valid, reliable self-report instrument for assessing quality of life. The minimum total score possible is 14 and the maximum total score possible is 70. The higher score the better satisfaction.
From Baseline to 8 Weeks Assessed
VAS-GI
Time Frame: From Baseline to 8 Weeks Assessed
Visual Analogue Scale for GI symptoms, VAS-GI (visual analogue scale, VAS 0-10) was designed to measure the response of symptoms and well-being in patients after taking probiotics.
From Baseline to 8 Weeks Assessed
Patient Global Impression scales of Improvement rated by patient, PGI-C
Time Frame: From Baseline to 8 Weeks Assessed
The PGIC is a single-item questionnaire that asks the patient to assess their TD symptoms at specific visits after initiating therapy. The PGIC uses a 7 point Likert Scale, ranging from very much worse (-3) to very much improved (+3), to assess overall response to therapy.
From Baseline to 8 Weeks Assessed
Serotonin
Time Frame: From Baseline to 8 Weeks Assessed
Levels of serotonin in serum
From Baseline to 8 Weeks Assessed
GABA
Time Frame: From Baseline to 8 Weeks Assessed
Levels of GABA in serum
From Baseline to 8 Weeks Assessed
Norepinephrine
Time Frame: From Baseline to 8 Weeks Assessed
Levels of Norepinephrine in serum
From Baseline to 8 Weeks Assessed
Immunoglobulin A, IgA
Time Frame: From Baseline to 8 Weeks Assessed
Levels of Immunoglobulin A, IgA in serum
From Baseline to 8 Weeks Assessed
adrenocorticotropic hormone, ACTH
Time Frame: From Baseline to 8 Weeks Assessed
Levels of adrenocorticotropic hormone, ACTH in serum
From Baseline to 8 Weeks Assessed
Total Antioxidant Capacity , TAC
Time Frame: From Baseline to 8 Weeks Assessed
Levels of Total Antioxidant Capacity , TAC in serum
From Baseline to 8 Weeks Assessed

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 19, 2024

Primary Completion (Actual)

July 31, 2024

Study Completion (Actual)

August 26, 2024

Study Registration Dates

First Submitted

April 19, 2024

First Submitted That Met QC Criteria

April 19, 2024

First Posted (Actual)

April 24, 2024

Study Record Updates

Last Update Posted (Actual)

August 27, 2024

Last Update Submitted That Met QC Criteria

August 26, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • B031

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Disorder

Clinical Trials on probiotics

Subscribe